|  | Univariable analysis | Multivariable analysis | ||||||
---|---|---|---|---|---|---|---|---|---|
Variables | HR | 95% CI of HR | P | HR | 95% CI of HR | P | |||
Lower | Upper | Lower | Upper | ||||||
Training dataset (n = 73) | |||||||||
 Sex | Male vs. Female | 1.375 | 0.718 | 2.635 | 0.337 | 1.336 | 0.682 | 2.617 | 0.398 |
 Age | > 62 vs. ≤ 62 | 1.241 | 0.667 | 2.311 | 0.495 | 1.585 | 0.819 | 3.066 | 0.171 |
 pTNM stage | III, IV vs. I, II | 2.424 | 1.362 | 4.314 | 0.003 | 1.639 | 0.884 | 3.039 | 0.117 |
 circRNA-signature | High risk vs. low risk | 7.746 | 3.519 | 17.051 | 0.000 | 6.705 | 2.951 | 15.237 | 0.000 |
Test set (n = 125) | |||||||||
 Sex | Male vs. Female | 1.185 | 0.659 | 2.130 | 0.570 | 1.109 | 0.614 | 2.003 | 0.732 |
 Age | > 62 vs. ≤ 62 | 0.987 | 0.543 | 1.793 | 0.966 | 1.084 | 0.596 | 1.974 | 0.791 |
 pTNM stage | III, IV vs. I, II | 1.825 | 1.163 | 2.863 | 0.009 | 1.635 | 1.032 | 2.590 | 0.036 |
 circRNA signature | High risk vs. low risk | 2.794 | 1.484 | 5.260 | 0.001 | 2.583 | 1.363 | 4.896 | 0.004 |